Stem Cell Authority, Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCAL research report →
Companywww.stemcellauthority.com
Stem Cell Authority, Ltd. , a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child.
- CEO
- Carlzo Bernard Cardwell
- IPO
- 2005
- HQ
- Fairlawn, OH, US
Price Chart
Valuation
- Market Cap
- $17.42K
- P/E
- -45.87
- P/S
- 0.00
- P/B
- -2.41
- EV/EBITDA
- -4.12
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 7.07%
- ROIC
- 5.25%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-4,233 · 0.00%
- EPS
- $0.00 · 0.00%
- Op Income
- $-4,230
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.99
- Avg Volume
- 16
Get TickerSpark's AI analysis on SCAL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SCAL Coverage
We haven't published any research on SCAL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SCAL Report →